Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Molecular Templates Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Molecular Templates Raises USD40 million in Venture Financing 12
Molecular Templates Raises Additional USD3.5 Million in Series C Financing 14
Molecular Templates Raises USD7 Million in Venture Financing 15
Molecular Templates Raises US$8.5 Million In Series C Financing 16
Partnerships 17
Molecular Templates Enters into Agreement with Takeda Pharma 17
AbCheck and Molecular Templates Enter into Agreement 18
Takeda Pharma Enters into Research Agreement with Molecular Templates 19
Molecular Templates Enters into Research Agreement with MD Anderson Cancer Center 20
Molecular Templates Enters into Agreement with Veristat 21
Merger 22
Molecular Templates Merges with Threshold Pharma 22
Equity Offering 24
Molecular Templates Raises USD52 Million in Public Offering of Shares 24
Molecular Templates Files Registration Statement to Raise Funds through Public Offering of Shares 26
Molecular Templates Raises USD20 million in Equity Financing 27
Acquisition 28
Threshold Pharma Acquires Molecular Templates 28
Molecular Templates Inc – Key Competitors 30
Molecular Templates Inc – Key Employees 31
Molecular Templates Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Strategy And Business Planning 33
Sep 21, 2018: Takeda and Molecular Templates partner on protein-based cancer therapy 33
Financial Announcements 34
Aug 09, 2018: Molecular Templates reports second quarter 2018 financial results 34
May 14, 2018: Molecular Templates Announces First Quarter 2018 Financial Results 36
Mar 28, 2018: Molecular Templates Announces Fourth Quarter 2017 Financial Results 37
Nov 14, 2017: Molecular Templates Reports Third Quarter 2017 Financial Results 39
Corporate Communications 41
Nov 14, 2017: Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer 41
Product News 43
10/24/2017: OBI Pharma Announces Presentation on OBI-3424 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 43
Product Approvals 44
Jul 09, 2018: OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Hepatocellular Carcinoma (HCC) 44
Apr 18, 2018: OBI Pharma Announces FDA Clearance of OBI-3424 IND Application for A Phase I/II Study Targeting AKR1C3 Solid Tumors 45
Clinical Trials 46
Mar 15, 2018: New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research Annual Meeting 2018 46
Oct 29, 2017: OBI Pharma announces OBI-3424 results from the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 47
Jun 13, 2017: Threshold Pharmaceuticals Announces First Patient Dosed in Immunotherapy Clinical Trial of Evofosfamide and Ipilimumab 48
Mar 30, 2017: Molecular Templates Announces Presentation on MT-4019 at the 2017 American Association for Cancer Research Annual Meeting 49
Other Significant Developments 50
Jan 05, 2018: Molecular Templates Provides Corporate Update and Outlines 2018 Milestones 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
Molecular Templates Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Molecular Templates Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Molecular Templates Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Molecular Templates Raises USD40 million in Venture Financing 12
Molecular Templates Raises Additional USD3.5 Million in Series C Financing 14
Molecular Templates Raises USD7 Million in Venture Financing 15
Molecular Templates Raises US$8.5 Million In Series C Financing 16
Molecular Templates Enters into Agreement with Takeda Pharma 17
AbCheck and Molecular Templates Enter into Agreement 18
Takeda Pharma Enters into Research Agreement with Molecular Templates 19
Molecular Templates Enters into Research Agreement with MD Anderson Cancer Center 20
Molecular Templates Enters into Agreement with Veristat 21
Molecular Templates Merges with Threshold Pharma 22
Molecular Templates Raises USD52 Million in Public Offering of Shares 24
Molecular Templates Files Registration Statement to Raise Funds through Public Offering of Shares 26
Molecular Templates Raises USD20 million in Equity Financing 27
Threshold Pharma Acquires Molecular Templates 28
Molecular Templates Inc, Key Competitors 30
Molecular Templates Inc, Key Employees 31
Molecular Templates Inc, Subsidiaries 32
List of Figures
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9